Low Potassium, Histidine/Histidine HCl Buffered, Cardioplegic Solution as a Replacement for Typical High Potassium Solutions To Produce Myocardial Quiescence And Protection: A Case Report (EP Video)
This meta-analysis suggested that, peri-operative administration of LEVO was not associated with increased risks of post-operative bleeding and blood transfusion requirement in cardiac surgical patients.
APP has 5 mL Novaplus vials available for direct order only because they have an expiration date of July, 2011. The 25 mL Novaplus vials are on back order and the company cannot estimate a release date.
In this review, we describe the protective role of VNS in myocardial I/R injury and related potential mechanisms. Then, we discuss the challenge and the opportunity of VNS in the treatment of acute myocardial I/R injury.
